155 related articles for article (PubMed ID: 21404598)
21. Evidence for
Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
[TBL] [Abstract][Full Text] [Related]
22. Case Report: Multidrug-Resistant
Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
[TBL] [Abstract][Full Text] [Related]
23. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
24. Progress in the chemotherapy of leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
[No Abstract] [Full Text] [Related]
25. A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries.
Matsuoka M; Aye KS; Kyaw K; Tan EV; Balagon MV; Saunderson P; Gelber R; Makino M; Nakajima C; Suzuki Y
J Med Microbiol; 2008 Oct; 57(Pt 10):1213-1219. PubMed ID: 18809547
[TBL] [Abstract][Full Text] [Related]
26. Active surveillance of leprosy contacts in country with low prevalence rate.
Kai M; Maeda Y; Maeda S; Fukutomi Y; Kobayashi K; Kashiwabara Y; Makino M; Abbasi MA; Khan MZ; Shah PA
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):50-3. PubMed ID: 15217314
[TBL] [Abstract][Full Text] [Related]
27. Detection of drug-resistant Mycobacterium leprae using molecular methods.
Williams DL; Gillis TP
Indian J Lepr; 1999; 71(1):137-53. PubMed ID: 10439334
[No Abstract] [Full Text] [Related]
28. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
29. Drug-resistant M leprae.
Saunderson PR
Clin Dermatol; 2016; 34(1):79-81. PubMed ID: 26773627
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
31. Surveillance of drug resistance in leprosy: 2010.
Wkly Epidemiol Rec; 2011 Jun; 86(23):237. PubMed ID: 21661275
[No Abstract] [Full Text] [Related]
32. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
33. Dormancy, drug resistance or dependency; some thoughts to ponder.
Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
[No Abstract] [Full Text] [Related]
34. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
35. Molecular surveillance of antimicrobial resistance and transmission pattern of
Chokkakula S; Chen Z; Wang L; Jiang H; Chen Y; Shi Y; Zhang W; Gao W; Yang J; Li J; Li X; Shui T; He J; Shen L; Liu J; Wang D; Wang H; Chen H; Kuang Y; Li B; Chen Z; Wu A; Yu M; Yan L; Suryadevara NC; Vissa V; Liu W; Wang H
Emerg Microbes Infect; 2019; 8(1):1479-1489. PubMed ID: 31621517
[TBL] [Abstract][Full Text] [Related]
36. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
Kai M
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
[TBL] [Abstract][Full Text] [Related]
37. [Drug resistance of multibacillary leprosy patients in Japan--results of molecular genetic analyses].
Ozaki M
Nihon Hansenbyo Gakkai Zasshi; 2008 Sep; 77(3):187-96. PubMed ID: 18800639
[TBL] [Abstract][Full Text] [Related]
38. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
39. [DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Suzuki Y; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):271-7. PubMed ID: 17037383
[TBL] [Abstract][Full Text] [Related]
40. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]